Samlyn Capital LLC Takes $94.98 Million Position in CME Group Inc. $CME

Key Points

• Samlyn Capital LLC has acquired a new position in CME Group Inc., purchasing 358,011 shares valued at approximately $94.98 million in Q1, now making up 1.4% of its portfolio.
• CME Group reported a 10.4% year-over-year increase in revenue, with quarterly earnings of $2.96 per share exceeding analyst expectations.
• The company announced a quarterly dividend of $1.25 per share, reflecting a dividend yield of 1.9%, with a payout ratio of 48.40%.

Samlyn Capital LLC acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 358,011 shares of the financial services provider's stock, valued at approximately $94,977,000. CME Group accounts for approximately 1.4% of Samlyn Capital LLC's portfolio, making the stock its 26th biggest holding. Samlyn Capital LLC owned about 0.10% of CME Group at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CME. Wayfinding Financial LLC purchased a new stake in shares of CME Group during the first quarter worth approximately $25,000. Cornerstone Planning Group LLC raised its stake in shares of CME Group by 122.2% during the first quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC raised its stake in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management purchased a new stake in shares of CME Group during the first quarter worth approximately $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in shares of CME Group during the first quarter worth approximately $32,000. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CME has been the subject of several analyst reports. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. Piper Sandler increased their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Oppenheimer increased their price objective on CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. UBS Group cut their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday. Finally, Citigroup raised their price target on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Four investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $260.60.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard purchased 256 shares of the firm's stock in a transaction on Wednesday, June 25th. The shares were purchased at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director owned 258,196 shares in the company, valued at approximately $69,849,763.88. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

CME Group stock traded down $1.05 during midday trading on Tuesday, reaching $261.53. 1,943,410 shares of the company were exchanged, compared to its average volume of 1,910,045. The company has a market capitalization of $94.25 billion, a price-to-earnings ratio of 25.32, a P/E/G ratio of 4.75 and a beta of 0.43. The firm's 50-day simple moving average is $274.42 and its 200-day simple moving average is $270.18. CME Group Inc. has a 1 year low of $212.38 and a 1 year high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company earned $2.56 EPS. The firm's quarterly revenue was up 10.4% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.